Recent Finacing
Recent Raise
Syndexa Pharmaceuticals discovers and develops small‑molecule ER‑modulating drugs, advancing preclinical programs targeting metabolic, inflammatory, cardiovascular, and neurodegenerative indications from its Watertown, MA research base.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor